StockDuty ← Dashboard Nov 04, 2026 07:50 AM ET
SignalCorporate

Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook

Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook.

Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook.
Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook. — impact context not separately stored; see What changed.
Sources